Zobrazeno 1 - 10
of 47
pro vyhledávání: ''
Autor:
Haibo Ding, Lin Wang, Zhen Wang, Minghui An, Bin Zhao, Xiaoxu Han, Lu Wang, Xin Li, Wei Song, Xue Dong, Wen Tian
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Metho
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Mycobacterium abscessus is a rapidly growing mycobacteria involved in severe infections of the lung, skin, or soft tissue. Macrolides such as clarithromycin are the recommended first line drugs for treatment of M. abscessus infections. How
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Fluoroquinolones are commonly recommended as treatment for urinary tract infections (UTIs). The development of resistance to these agents, particularly in gram-negative microorganisms complicates treatment of infections caused by these org
Autor:
Vesna Cvitković Špik, Tanja Selič-Kurinčič, Tatjana Avšič-Županc, Miha Simoniti, Mitja Lenart, Katja Strašek-Smrdel
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-4 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Candidatus Neoehrlichia mikurensis (CNM) is an emerging tick-born pathogen and usually causes symptomatic infection only in immunocompromised patients. Apart from one described case found in the literature where cultivation was successful,
Autor:
Reetika Dawar, Vandana Rani, Shimpi Chopra, Raman Sardana, Rajni Gaind, Gajanand Mittal, Vasundhra Bhandari, Pardeep Kumar Verma
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important to under
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Isoniazid resistant tuberculosis is the most prevalent type of resistance in Swaziland and over two-thirds of the isoniazid resistant tuberculosis patients are tuberculosis and human immunodeficiency virus co-infected. The study aimed to d
Autor:
Belete Tegbaru, Gaetano Marrone, Sebastian Grossmann, Solomon Gebre-Selassie, Anders Sönnerborg, Daniel Fekade, Amare Worku Kalu, Ujjwal Neogi, Nigus Fikrie Telele
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Antiretroviral therapy (ART) was rolled-out in Ethiopia in 2005, but there are no reports on outcome of ART and human immunodeficiency virus drug resistance (HIVDR) at national level. We described acquired drug resistance mutations in pol
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-6 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Malaria continues to be a public health problem and important cause of morbidity and mortality in Ethiopia. Due to continuous interventions to combat malaria in endemic regions, a decline in malaria related deaths and morbidity has been re
Autor:
Jørgen Skov Jensen, Carmen Fernández, Orestes Blanco, Javier Couri, Brian A. Mondeja, Nadia Rodríguez
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Infectious Diseases
BMC Infectious Diseases
Background The increasing prevalence of macrolide resistant Mycoplasma genitalium is a major concern worldwide. In Cuba, several cases of clinical treatment failure with 1 g single dose and extended azithromycin regimen have been detected and the aim
Autor:
Mailis Laht, Age Brauer, Tanel Tenson, Maido Remm, Veljo Kisand, Irja Lutsar, Kaidi Telling, Matti Maimets
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Infectious Diseases
BMC Infectious Diseases
Background We aimed to identify the main spreading clones, describe the resistance mechanisms associated with carbapenem- and/or multidrug-resistant P. aeruginosa and characterize patients at risk of acquiring these strains in Estonian hospitals. Met